Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Psoriatic arthritis: treatment strategies using biologic agents

S. D'Angelo, C. Palazzi, I. Olivieri

113-121

05-06-2012

https://doi.org/10.4081/reumatismo.2012.113

1258

PDF: 1156
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

J. Mencarini, M. Spinicci, F. Bartalesi

144-147

16-12-2016

https://doi.org/10.4081/reumatismo.2016.897

1846

PDF: 1112
Psoriatic arthritis. When the heterogeneity requires normality

L. Punzi, R. Ramonda

59-65

05-06-2012

https://doi.org/10.4081/reumatismo.2012.59

848

PDF: 681
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

623

PDF: 558
Effects of TNF antagonists on immune and neuroendocrine system

G. Valesini, M. Cutolo

3-7

https://doi.org/10.4081/reumatismo.2005.4s.3

1162

PDF: 739
MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

132-139

https://doi.org/10.4081/reumatismo.2009.132

1901

PDF: 1128
Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

1-3

28-03-2013

https://doi.org/10.4081/reumatismo.2013.1

2272

PDF: 706
IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

S. Loffredo, F. Ayala, G.C. Marone, A. Genovese, G. Marone

28-39

https://doi.org/10.4081/reumatismo.2007.1s.28

955

PDF: 756
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1604

PDF: 993
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

31-38

https://doi.org/10.4081/reumatismo.2006.31

1779

PDF: 2517
Approved indications and other possible utilizations of anti-TNFa biologic drugs

W. Grassi, C. Montecucco

30-33

https://doi.org/10.4081/reumatismo.2005.4s.30

1129

PDF: 872
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

52-59

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1266

1923

PDF: 1078
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

07-01-2025

https://doi.org/10.4081/reumatismo.2025.1682

1048

PDF: 31
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

182-186

https://doi.org/10.4081/reumatismo.2009.182

996

PDF: 694

1 - 14 of 14 items

Search

Search Results

Psoriatic arthritis: treatment strategies using biologic agents

Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

Psoriatic arthritis. When the heterogeneity requires normality

BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

Effects of TNF antagonists on immune and neuroendocrine system

MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Approved indications and other possible utilizations of anti-TNFa biologic drugs

Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

authors

reviewers

Categories

indexing

Keywords